CION Ameerpet
Tamoxifen is a tablet that blocks oestrogen from feeding hormone-receptor-positive breast cancer. For many women, especially before menopause, it lowers the chance of the cancer coming back. Here is what it does, the side effects you may feel, and how our oncologists help you take it for the full 5 to 10 years.
Tamoxifen is a hormone (endocrine) therapy taken as a daily tablet. It belongs to a group of drugs called selective oestrogen receptor modulators (SERMs). It is prescribed for breast cancers that are hormone-receptor-positive — meaning the tumour cells carry oestrogen receptors (ER-positive) and/or progesterone receptors (PR-positive). Roughly 7 in 10 breast cancers are hormone-receptor-positive, so tamoxifen is one of the most widely used breast cancer medicines in the world.
It is most often used after surgery (called adjuvant therapy) to lower the chance the cancer returns. It is also used to treat DCIS, to treat advanced or returned hormone-positive breast cancer, and sometimes to reduce risk in women with a strong family history. Your oncologist confirms hormone-receptor status from your biopsy report before starting it.
Tamoxifen is the main hormone therapy before menopause, sometimes combined with ovarian suppression. Aromatase inhibitors do not work alone in premenopausal women, which is why tamoxifen is so important for younger patients.
May start on tamoxifen or switch to it if aromatase inhibitors cause too many joint or bone side effects. Both routes are valid and chosen for your situation.
Used after surgery for non-invasive DCIS, and offered to some high-risk women to lower the chance of ever developing breast cancer.
Continued as long as it keeps the cancer controlled, often alongside other targeted medicines.
About 7 in 10 breast cancers are hormone-receptor-positive, and for these tamoxifen can cut the risk of the cancer returning. Large trial data show that taking it for the recommended duration also reduces deaths from breast cancer — yet many women stop early because of side effects. Staying the course, with side effects actively managed, is one of the most powerful steps a woman can take after surgery. Source: NCCN guidelines and the EBCTCG / ATLAS trial data.
Hormone-receptor-positive breast cancer cells use the body's own oestrogen as fuel to grow and divide. Tamoxifen works by sitting on the oestrogen receptor inside the cancer cell and blocking oestrogen from attaching. With the fuel supply cut off, the cancer cells stop multiplying and many die off.
This is why tamoxifen is sometimes called an “anti-oestrogen” in breast tissue. Interestingly, the same drug behaves differently in other parts of the body — it can mildly mimic oestrogen in the womb lining and bones, which explains both some of its protective effects and its risks. It is not chemotherapy: it does not destroy healthy fast-growing cells the way chemo does, so it does not cause hair loss in the way chemo can.
Binds oestrogen receptors on cancer cells so circulating oestrogen cannot switch them on.
Starves hormone-driven cells, reducing the chance of recurrence after surgery.
A tablet reaches cancer cells anywhere, including microscopic ones left after surgery.
The standard dose is usually 20 mg once a day, taken by mouth at about the same time each day, with or without food. If you miss a dose, take it when you remember unless it is almost time for the next one — never double up. Tamoxifen is taken every day for years, so building it into a daily routine (for example, with breakfast) helps you stay consistent.
How long you take it depends on your individual risk of recurrence. Large studies such as the ATLAS trial showed that continuing tamoxifen for 10 years instead of 5 further reduced both the chance of the cancer returning and the chance of dying from breast cancer — with the benefit appearing strongest in the years after treatment ends. For premenopausal women in particular, ASCO guidance supports offering 5 years first, then continuing to a total of 10 years if you remain premenopausal and are tolerating it well.
Usually one 20 mg tablet daily. Your doctor may adjust this; do not change the dose yourself.
The minimum proven course for early hormone-positive breast cancer and the standard for DCIS and risk reduction.
Extended therapy lowers recurrence further. The ATLAS trial showed fewer recurrences and deaths with 10 years versus 5.
At CION the duration is reviewed by medical, surgical and radiation oncologists together, balancing your recurrence risk against side effects.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Free first consultation for all cancer patients. Confidential, doctor-led, and never rushed.
Most women take tamoxifen for years with side effects that are manageable. The common ones are menopause-like and often ease over the first few months. The serious risks are uncommon but real, which is why regular follow-up matters. Tell your oncologist about any new symptom — many side effects can be reduced rather than endured. The list below covers what to watch for and what we do about it.
The most common effect. Usually settle with time. Dressing in layers, avoiding triggers like spicy food, caffeine and alcohol, and keeping the bedroom cool help. If severe, your oncologist can suggest non-hormonal options or, where appropriate, a divided dose. We never recommend hormone replacement therapy to treat them.
Many women worry about weight gain. Large studies, including one of over 3,000 survivors, found tamoxifen itself was not clearly linked to weight gain — weight often changes because of reduced activity, chemotherapy or menopause. We connect you with our nutritionist and recommend regular walking to stay on track.
Tamoxifen slightly raises the risk of clots in the legs or lungs. Seek urgent care for a hot, swollen, painful calf or sudden breathlessness or chest pain. Tell us before any surgery or long flight, and stay mobile and well-hydrated. Risk is higher if you smoke.
Tamoxifen can thicken the womb lining and slightly raises endometrial cancer risk, mainly in postmenopausal women — premenopausal women are not affected the same way. Report any abnormal vaginal bleeding promptly. We arrange a gynaecology review for any bleeding so it can be checked early, when it is most treatable.
Periods may become irregular or stop, but tamoxifen is not a contraceptive. Some women notice low mood, reduced libido or vaginal dryness. These are common, treatable, and worth raising — our psycho-oncology team can help where mood is affected.
Rarely, tamoxifen can affect the eyes (including cataracts) or liver. We recommend a routine eye check if you notice vision changes, and your liver function is monitored through your blood tests during treatment.
Tamoxifen is switched on in the body by a liver enzyme called CYP2D6. Medicines that block this enzyme can make tamoxifen less effective, so it is important your oncologist knows every tablet, supplement and herbal remedy you take — including ones bought without a prescription. Never stop a prescribed antidepressant on your own; instead, ask us to choose one that does not interfere.
Fluoxetine, paroxetine and bupropion can reduce how well tamoxifen works. Safer alternatives exist — tell us if you take any antidepressant so we can adjust, not stop, your treatment.
Tamoxifen should not be taken at the same time as anastrozole, letrozole or exemestane. These are sequenced, not combined.
Tamoxifen can increase the effect of warfarin and similar anticoagulants, raising bleeding risk. Extra monitoring is needed.
Grapefruit and grapefruit juice may interfere with how tamoxifen is processed; heavy alcohol can worsen hot flushes. Moderation is sensible.
Avoid oestrogen-containing products and discuss any herbal supplement (including phyto-oestrogens) with us before starting it.
This is one of the most important sections for younger women. Tamoxifen must not be taken during pregnancy or breastfeeding — it can cause birth defects. Because tamoxifen is not itself a contraceptive and you can still become pregnant, you should use non-hormonal contraception (such as condoms or a copper IUD) throughout treatment and for about two months after stopping.
If you hope to have children, raise it before you start. Fertility preservation can often be arranged before treatment, and the recent POSITIVE trial showed that some women can safely pause hormone therapy for a defined period to try for a pregnancy, then resume — a decision made carefully with your oncologist. At CION we discuss fertility openly at the first consultation, because it is far easier to plan ahead than to react later.
Risk of birth defects. Use reliable non-hormonal contraception during treatment and for ~2 months after stopping.
Egg or embryo preservation can often be done before starting. Tell us at the first visit if you may want children.
The POSITIVE trial supports a carefully timed break to attempt pregnancy for selected women — only under specialist guidance.
The hardest part of tamoxifen is not starting it — it is staying on it for 5 to 10 years. Many women stop early because of side effects, which raises the risk of the cancer returning. Our hormone-therapy follow-up is built to keep you on track with the least possible disruption to your life. Every plan begins with a 45-minute consultation and is reviewed by our tumor board, so your duration and dose reflect a team decision, not one opinion.
With 150+ years of combined oncology experience, 17 super-specialist oncologists and 35+ centres across Telangana & AP, we have cared for 15,000+ patients and hold a 4.8/5 Google rating across centres. For breast cancer, CION's 1-year survival is 96.9% versus a national average of 85.4%*.
Regular check-ins to catch and treat hot flushes, mood changes and other effects early, so you can keep taking the tablet.
Prompt gynaecology review for any abnormal vaginal bleeding, and clear advice on what to watch for at home.
Access to our nutritionist and psycho-oncology team to manage weight, energy and mood through the years of treatment.
Medical, surgical and radiation oncologists review your plan together — decisions for healing, not billing.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP), compared with CION patient outcomes. CION figures are network outcomes; national figures are population averages and do not predict an individual's result.
Hear from CION patients on hormone therapy — in their own words.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No. Tamoxifen is hormone (endocrine) therapy, not chemotherapy. It works by blocking oestrogen from feeding hormone-receptor-positive breast cancer cells, rather than by destroying fast-dividing cells the way chemotherapy does. That is why it is taken as a daily tablet at home and does not cause the hair loss or low blood counts typical of chemo. Some women have chemotherapy first and then take tamoxifen afterwards to lower the chance of the cancer returning. Your oncologist will explain exactly where tamoxifen fits in your overall treatment plan.
It depends on your individual risk of recurrence. Five years is the proven minimum for early hormone-positive breast cancer. The ATLAS trial showed that continuing to 10 years further reduced both recurrence and deaths from breast cancer, with the benefit growing in the years after treatment. For premenopausal women, guidelines support starting with 5 years and continuing to 10 if you remain premenopausal and are tolerating it well. At CION this decision is reviewed by our tumor board, weighing your recurrence risk against side effects, so you get a team recommendation rather than a one-size answer.
Although weight gain is sometimes listed as a side effect, good research does not show a strong link between tamoxifen itself and gaining weight. One study of over 3,000 breast cancer survivors found tamoxifen was not clearly associated with weight gain, while chemotherapy was. Weight often changes during treatment because of reduced activity, menopause or other medicines rather than the tamoxifen tablet. Regular walking, a balanced diet rich in vegetables and lean protein, and support from our nutritionist all help. If you are gaining weight and it worries you, tell your oncologist so other causes can be checked.
Tamoxifen can thicken the lining of the womb and slightly increases the risk of endometrial cancer, but this risk mainly applies to postmenopausal women; premenopausal women are not affected in the same way. The overall risk is small and is far outweighed by tamoxifen's benefit in preventing breast cancer recurrence. The key safety step is simple: report any abnormal vaginal bleeding to your doctor promptly so it can be investigated early. At CION we arrange a gynaecology review for any unexpected bleeding, because problems found early are the most treatable.
Tell your oncologist about every medicine and supplement you take, because some interact with tamoxifen. Certain antidepressants (fluoxetine, paroxetine, bupropion) can make it less effective, so these should be reviewed rather than stopped on your own. Avoid taking tamoxifen at the same time as aromatase inhibitors. Grapefruit and grapefruit juice may interfere with how the drug is processed, and heavy alcohol can worsen hot flushes. Avoid oestrogen-containing products and discuss any herbal remedy before using it. Do not get pregnant while taking tamoxifen, as it can cause birth defects.
No. Tamoxifen can cause birth defects, so you must not be pregnant or breastfeed while taking it. Because it does not act as a contraceptive and you can still conceive, use non-hormonal contraception (such as condoms or a copper IUD) during treatment and for about two months after stopping. If you hope to have children, raise it before you start so fertility preservation can be arranged. The recent POSITIVE trial showed that some women can safely pause hormone therapy for a planned time to try for a pregnancy and then resume — a decision made carefully with your oncologist.
Common side effects such as hot flushes, night sweats or mild nausea often begin within the first few weeks and frequently ease over the first few months as your body adjusts. Some effects, like changes to periods, may persist while you are on treatment. Serious effects such as blood clots or abnormal womb bleeding are uncommon but need prompt attention at any point. The most important thing is not to suffer in silence: most side effects can be reduced through simple measures, dose timing or supportive care. Tell your CION oncologist about anything new at your follow-up visits.
Yes — tamoxifen is the main hormone therapy for premenopausal women with hormone-receptor-positive breast cancer. This is because aromatase inhibitors do not work on their own before menopause. Depending on your risk, your oncologist may combine tamoxifen with ovarian suppression for added protection. Premenopausal women also do not carry the same endometrial cancer risk that postmenopausal women do. Because younger women face issues around periods, fertility and pregnancy, we discuss all of this openly at your first 45-minute consultation so your plan fits your life as well as your cancer.